Origins of MAPS

Rick shares the fascinating journey of founding MAPS in 1986, driven by the need to protect MDMA as a therapeutic substance amidst growing legal challenges. Highlighting the importance of scientific validation, he emphasizes the shift from legal battles to a focus on FDA approval for psychedelics, showcasing the potential benefits for those in need. His insights reveal the long-standing commitment to advancing the understanding and acceptance of psychedelics in medicine.